104 related articles for article (PubMed ID: 2448369)
1. The renal antihypertensive effect of angiotensin I converting enzyme inhibitors.
Matsukawa S; Suzuki H; Itaya Y; Kumagai H; Saruta T
J Hypertens; 1987 Dec; 5(6):705-10. PubMed ID: 2448369
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive action of angiotensin-I converting enzyme inhibitors in the kidney.
Matsukawa S; Suzuki H; Itaya Y; Kumagai H; Saruta T
Clin Exp Hypertens A; 1987; 9(2-3):391-4. PubMed ID: 3038401
[TBL] [Abstract][Full Text] [Related]
3. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Zimmerman BG; Goering JL; Raich PC
Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
[TBL] [Abstract][Full Text] [Related]
4. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
5. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
Textor SC; Brunner HR; Gavras H
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
[TBL] [Abstract][Full Text] [Related]
6. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
Chiba S; Quilley CP; McGiff JC
Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
[TBL] [Abstract][Full Text] [Related]
7. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
Am J Physiol; 1997 Feb; 272(2 Pt 2):H679-87. PubMed ID: 9124424
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II enhances norepinephrine spillover during sympathetic activation in conscious rabbits.
Noshiro T; Shimizu K; Way D; Miura Y; McGrath BP
Am J Physiol; 1994 May; 266(5 Pt 2):H1864-71. PubMed ID: 8203585
[TBL] [Abstract][Full Text] [Related]
9. Effects of nicardipine on the systemic and renal hemodynamics in acutely elevated blood pressure induced by vasoactive agents in conscious rabbits.
Matsukawa S; Suzuki H; Itaya Y; Kumagai H; Saruta T
Jpn Heart J; 1987 May; 28(3):435-43. PubMed ID: 3626025
[TBL] [Abstract][Full Text] [Related]
10. Control of renal function by intrarenal angiotensin II in the dog.
Levens NR
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S65-9. PubMed ID: 1705631
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
12. Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.
Antonaccio MJ; Kerwin L
Hypertension; 1981; 3(3 Pt 2):I54-62. PubMed ID: 6167515
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II contributes to cerebral vasodilatation during hypoxia in the rabbit.
Maktabi MA; Todd MM; Stachovic G
Stroke; 1995 Oct; 26(10):1871-6. PubMed ID: 7570741
[TBL] [Abstract][Full Text] [Related]
15. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
[TBL] [Abstract][Full Text] [Related]
16. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
17. Abolition of long-term vascular influence of renin-angiotensin system.
Randall RD; Zimmerman BG
Am J Physiol; 1990 Aug; 259(2 Pt 2):H543-53. PubMed ID: 2167025
[TBL] [Abstract][Full Text] [Related]
18. Vasoregulatory hormones and the hyperfiltration of diabetes.
Bank N; Lahorra MA; Aynedjian HS; Schlondorff D
Am J Physiol; 1988 Feb; 254(2 Pt 2):F202-9. PubMed ID: 2449821
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Paula RD; Lima CV; Khosla MC; Santos RA
Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
